Bausch Health to Acquire Option to Purchase Allegro Ophthalmics Assets

Bausch Health Companies Inc. and Bausch + Lomb and Allegro Ophthalmics a privately held biopharmaceutical company focused on the development of novel therapies that regulate integrin functions for the treatment of ocular diseases, announced that Bausch Health has entered into an agreement to acquire an option to purchase all ophthalmology assets of Allegro, including global rights for risuteganib (Luminate®), Allegro’s lead investigational compound in retina, which is believed to simultaneously act on various pathways implicated in intermediate dry Age-related Macular Degeneration (AMD).

Globally, the prevalence of AMD is expected to reach 196 million people this year and to increase to 288 million by 2040. Approximately 90% of people diagnosed with AMD have dry AMD, for which there are currently no treatments.

“As part of the ongoing transformation of Bausch Health, we continue to seek strategic opportunities to build-up our pipeline in core businesses, including Bausch + Lomb, our global eye health business. The addition of the ophthalmic assets of Allegro would significantly enhance our comprehensive portfolio of products for AMD,” said Joseph C. Papa, chairman and CEO of Bausch Health. “If approved, risuteganib may be the first treatment indicated to help reverse vision loss due to dry AMD and would address a significant unmet medical need affecting millions of people globally.”

Vicken Karageozian, M.D., president and CEO, Allegro said, “As we prepare for our Phase 3 clinical program, we look forward to working closely with Bausch Health on the united goal of one day being able to offer a treatment option to the millions of people who are currently losing their vision to dry AMD.”

Risuteganib is an investigational integrin-regulating therapy that is believed to reduce mitochondrial dysfunction involved in intermediate dry AMD. By targeting multiple pathways, risuteganib may help reduce the cellular burden of oxidative stress and restore retinal homeostasis. Two concurrent Phase 3 studies evaluating the use of intravitreal risuteganib to treat intermediate dry AMD are expected to begin within the next 12 months.

Other ophthalmology assets of Allegro include a topical agent under investigation for the treatment of dry eye disease currently in Phase 2 development.

Click HERE for the full press release.

Featured Posts

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Learn More

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read more

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read more

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read more

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Learn More

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read More

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read More

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read More

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read More

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Learn More

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read more

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read more

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read more

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Learn More

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read more

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read more

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read more